WellManaged – Heart Failure Program
Heart Failure costs the nation an estimated $30.7 billion annually.
February is American Heart Month, a time to raise awareness about heart disease and provide prevention information. Approximately 5 million Americans are currently living with heart failure and 960,000 new cases are diagnosed every year. Heart failure is responsible for 11 million physician visits annually and more hospitalizations than all forms of cancer combined. Due to the prevalence of heart-related conditions in our society and the costs associated with treating them, WellDyneRx launched the WellManaged – Heart Failure program.
Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body’s needs. Initially, the heart compensates for its inability to function normally by becoming enlarged, developing more muscle mass, and/or by pumping faster. Patients with heart failure usually present in one of three ways:
- Decreased exercise tolerance (with shortness of breath and/or fatigue)
- Fluid retention with abdominal or leg swelling
- Evidence of cardiac enlargement or dysfunction may be discovered during evaluation for another disorder
The long-term goals for the management of heart failure are to improve the patient’s clinical status
and functional capacity. Accordingly, clinicians strive to reduce hospital admissions, improve quality of life, and decrease morbidity and mortality rates associated with the condition. Beyond immediate treatments, long-term management goals include patient support, education, and monitoring. While medications provide symptom relief and can improve prognoses, patients must be actively engaged in their therapy and maintain medication adherence and adopt life-style modifications to optimize their outcomes.
Heart Failure Statistics1 –
- Congestive heart failure (CHF) is the first-listed diagnosis in 875,000 hospitalizations and the most common diagnosis in hospital patients aged 65 years and older
- More than half of patients diagnosed with CHF die within 5 years of diagnosis
- Heart failure (HF) contributes to approximately 287,000 deaths annually
- HF costs the nation an estimated $30.7 billion annually2 (includes cost of health care services, medications to treat HF, and missed days of work)
The WellManaged – Heart Failure program controls costs by ensuring members are prescribed the right medications at the right dosages. Clinical pharmacists promote drug adherence, address gaps in care, provide care management services, and generate outcomes reporting. Members receive ongoing patient education about their disease state and factors that may worsen their heart failure symptoms, as well as guidance regarding lifestyle modifications and treatment goals.
To learn more about the WellManaged – Heart Failure program, contact WellDyneRx.
1. ‘Heart Failure Facts and Information.’ The Heart Failure Society of America. The Heart Failure Society of America, Inc. http://www. hfsa.org. Accessed June 11, 2018.
2. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44.
2019 Quarter One WellInformed Table of Contents
- WellDyneRx Selected to Provide Pharmacy Services for DaVita’s Medicare Part B Bundled Program
- US Specialty Care Launches WellConnect Patient Engagement Platform to Improve Patient Care and Reduce Treatment Costs
- WellManaged – Migraines
- IRS High Deductible ￼Health Plan (HDHP) Rules
- Upcoming Conferences & Tradeshows
- FDA Approved List